The aim of this study is to describe Health Related Quality of Life (HRQoL) in adolescents
and adults with Hemophilia A treated prophylactically or on-demand with Helixate NexGen. The
study will also assess the kinds of determinants, including key transitional life events,
that might impact HRQoL in this patient population.